Department of Chemistry, Yale University, New Haven, CT 06520, United States.
Bioorg Med Chem Lett. 2010 Apr 1;20(7):2137-9. doi: 10.1016/j.bmcl.2010.02.043. Epub 2010 Feb 13.
A potential anti-HIV and HCV drug candidate is highly desirable as coinfection has become a worldwide public health challenge. A potent compound based on a tetrabutoxy-calix[4]arene scaffold that possesses dual inhibition for both HIV and HCV is described. Structural activity relationship studies demonstrate the effects of lower-rim alkylation in maintaining cone conformation and upper-rim interacting head groups on the calix[4]arene play key roles for its potent dual antiviral activities.
作为一种潜在的抗 HIV 和 HCV 药物候选物,具有抗 HIV 和 HCV 双重抑制作用的基于四丁氧基杯[4]芳烃骨架的有效化合物备受关注。本文描述了一种有效的化合物。构效关系研究表明,降低杯芳烃中环烷基化程度以维持锥形构象,以及上缘相互作用的头部基团在发挥其强效双重抗病毒活性方面发挥关键作用。